Lafora Disease Pages on BioPortfolio:

Biotechnology, Pharmaceutical and Life Science Email addresses for ...
Individuals are categorized by their professional expertise (e.g. specific to a gene, disease, molecule or technique). You can specify the type of ...
http://www.bioportfolio.com/advertis/bioemail.htm...

BioPortfolio.com - BioWeb Myoclonus Search
... Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease ... Hartung Type Lafora Disease, Included Baltic Myoclonus Epilepsy Lafora Body ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

Progressive Myoclonus Epilepsy Quest Diagnostics Patient Health ...
Myoclonic Epilepsy Hartung Type; Lafora Disease Included; Baltic Myoclonus Epilepsy; Lafora Body Disease; Unverricht Disease; UnverrichtLundborg Disease ...
http://www.bioportfolio.co.uk/cgi-bin/htm_hl.pl?DB=search&ST...

Antibody By Gene - E
... Healthcare Medical Life Science Drug Discovery Disease and Industry Portal ..... EPM2A epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) ...
http://www.bioportfolio.co.uk/antibody/genes-E.htm...

Results from other life science and pharmaceutical sites:

A Second Gene for Lafora Disease
We previously discovered that mutations in EPM2A cause Lafora disease. We identified a second gene associated with this disease, NHLRC1 (also called EPM2B), ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=53...

Genetic diagnosis in Lafora disease: genotype-phen...[Neurology ...
Lafora disease due to EPM2B mutations: a clinical and genetic study. ... 2005]; Clinical and genetic findings in 26 Italian patients with Lafora disease. ...
http://www.ncbi.nlm.nih.gov/pubmed/17389303...

Diagnosis by axilla skin biopsy in an early case of Lafora's disease.
Myoclonus, seizures and progressive dementia are the main clinical features in Lafora's disease. This is the first reported case in which the diagnosis has ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=10...

Lafora disease in the Indian population: EPM2A and...[Hum Mutat ...
Lafora disease (LD) is a fatal form of teenage-onset autosomal recessive ... Mutations in the NHLRC1 gene are the common cause for Lafora disease in the ...
http://www.ncbi.nlm.nih.gov/pubmed/18311786...

Identification of a recombination event narrowing the Lafora ...
This study for linkage of markers from the candidate gene region was performed in a previously unpublished family affected with Lafora disease. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=10...

Lafora disease, seizures and sugars. [Acta Myol. 2007] - PubMed Result
Lafora disease (LD) is the most severe form of Progressive Myoclonus Epilepsy with teenage onset. It has an autosomal recessive mode of inheritance and is ...
http://www.ncbi.nlm.nih.gov/pubmed/17915579...

Posterior paroxysmal discharge: an aid to early diagnosis in ...
Lafora body disease is a rare neurometabolic disorder of autosomal recessive inheritance. Symptoms begin in the second decade with progressive myoclonic ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=12...

The Lafora disease gene product laforin interacts ...[Hum Mol ...
Lafora disease is an autosomal recessive type of progressive myoclonus epilepsy caused by mutations in the EPM2A gene. The EPM2A gene-encoded protein ...
http://www.ncbi.nlm.nih.gov/pubmed/12915448...

Diagnosis by axilla skin biopsy in an early case of Lafora's disease.
[PubMed]; Iannaccone S, Zucconi M, Quattrini A, Nemni R, Comola M, Taccagni L, Smirne S. Early detection of skin and muscular involvement in Lafora disease. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=10...

Lafora disease is not linked to the Unverricht-Lun...[Am J Med ...
Lafora disease and Unverricht-Lundborg disease are two forms of progressive myoclonus epilepsies (PME). Recently the gene for Unverricht-Lundborg disease ...
http://www.ncbi.nlm.nih.gov/pubmed/7485240...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.